- Home
- IBKR vs TEVA Comparison
IBKR vs TEVA Comparison
Compare IBKR & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBKR
- TEVA
- Stock Information
- Founded
- IBKR 1977
- TEVA 1901
- Country
- IBKR United States
- TEVA Israel
- Employees
- IBKR N/A
- TEVA N/A
- Industry
- IBKR Investment Bankers/Brokers/Service
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- IBKR Finance
- TEVA Health Care
- Exchange
- IBKR Nasdaq
- TEVA Nasdaq
- Market Cap
- IBKR 18.9B
- TEVA 18.4B
- IPO Year
- IBKR 2007
- TEVA N/A
- Fundamental
- Price
- IBKR $164.72
- TEVA $15.08
- Analyst Decision
- IBKR Strong Buy
- TEVA Strong Buy
- Analyst Count
- IBKR 8
- TEVA 6
- Target Price
- IBKR $204.13
- TEVA $24.00
- AVG Volume (30 Days)
- IBKR 2.6M
- TEVA 11.4M
- Earning Date
- IBKR 04-15-2025
- TEVA 05-07-2025
- Dividend Yield
- IBKR 0.61%
- TEVA N/A
- EPS Growth
- IBKR 22.22
- TEVA N/A
- EPS
- IBKR 6.93
- TEVA N/A
- Revenue
- IBKR $5,200,000,000.00
- TEVA $16,544,000,000.00
- Revenue This Year
- IBKR $7.00
- TEVA $5.31
- Revenue Next Year
- IBKR $7.24
- TEVA $1.18
- P/E Ratio
- IBKR $23.77
- TEVA N/A
- Revenue Growth
- IBKR 17.65
- TEVA 4.41
- 52 Week Low
- IBKR $103.69
- TEVA $12.51
- 52 Week High
- IBKR $236.53
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- IBKR 34.90
- TEVA 33.93
- Support Level
- IBKR $170.45
- TEVA $15.28
- Resistance Level
- IBKR $183.73
- TEVA $15.80
- Average True Range (ATR)
- IBKR 6.55
- TEVA 0.57
- MACD
- IBKR 0.23
- TEVA -0.01
- Stochastic Oscillator
- IBKR 23.01
- TEVA 18.22
About IBKR Interactive Brokers Group Inc.
Interactive Brokers is an online brokerage that generates trading commissions (around 31% of net revenue) from facilitating trading in a wide range of products, including equity, options, futures, foreign exchange, bonds, mutual funds, and ETFs. Interactive Brokers also generates net interest income (about 64% of net revenue) from idle client cash and earns fees (about 6% of net revenue) from ancillary services. Principal trading and other miscellaneous activities are small (about 5% of net revenue). The firm derives about 70% of its net revenue from the U.S. and 30% from international markets.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.